A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2011
12/27/2011	US8084053 Dry mouldable drug formulation
12/27/2011	US8084051 Therapeutic medical garments with silicone sheeting component for scar treatment, process of manufacture and use
12/27/2011	US8084047 Compositions and methods for treatment of eye disorders
12/27/2011	US8084046 Incorporation of certain isoprenoid compounds into catamenial tampon to reduce or eliminate pathogenic microorganisms and menstrually occurring Toxic Shock Syndrome
12/27/2011	US8084045 Pharmaceutical formulations for the prolonged release of active principle(s) and their applications
12/27/2011	US8084037 Recombinant parainfluenza virus expression systems and vaccines
12/27/2011	US8084015 Immunostimulatory complex of a cationic peptide immunogen and anionic CpG single-stranded DNA oligonucleotide
12/27/2011	US8083730 Implantable therapeutic substance delivery device with reservoir volume sensor
12/27/2011	US8083710 Acoustically controlled substance delivery device
12/27/2011	US8083347 Drug delivery system and methods of use
12/22/2011	WO2011160136A2 Progesterone containing oral dosage forms and related methods
12/22/2011	WO2011160110A1 Novel formulation of pegylated-liposome encapsulated glycopeptide antibiotics
12/22/2011	WO2011160098A2 Silk optical particles and uses thereof
12/22/2011	WO2011159927A1 Chewing gum products containing ethyl ester of n-[[5-methyl-2-(1-methylethyl)-cyclohexyl] carbonyl] glycine
12/22/2011	WO2011159881A2 Il-10 and methods of treating ocular and other diseases
12/22/2011	WO2011159871A2 Compositions and methods for the treatment of addiction, psychiatric disorders, and neurodegenerative disease
12/22/2011	WO2011159635A1 Lysophosphatidic acid receptor antagonist for the treatment of dermal conditions
12/22/2011	WO2011159633A1 Inhalable formulations of lysophosphatdic acid receptor antagonists
12/22/2011	WO2011159626A1 Hydroxypropyl methyl cellulose acetate succinate with enhanced acetate and succinate substitution
12/22/2011	WO2011159550A2 Lysophosphatidic acid receptor antagonist and uses thereof
12/22/2011	WO2011159548A1 Composition for use as an assay reagent
12/22/2011	WO2011159491A2 Controlled release levetiracetam formulations
12/22/2011	WO2011159218A1 Apparatus and method for the production of particles
12/22/2011	WO2011158964A1 Transdermal absorption promoter, and external skin formulation thereof
12/22/2011	WO2011158933A1 Agent for treating renal fibrosis
12/22/2011	WO2011158870A1 Controlled release nucleated tablet
12/22/2011	WO2011158089A1 N-containing polymers in topical compositions to suppress metal induced allergic reactions
12/22/2011	WO2011158052A1 Nanostructured ezetimibe compositions, process for the preparation thereof and pharmaceutical compositions containing them
12/22/2011	WO2011158034A2 Compositions and methods
12/22/2011	WO2011157880A1 Antioxidant composition
12/22/2011	WO2011157798A1 Methods and compositions for stimulating reepithelialisation during wound healing
12/22/2011	WO2011157730A1 Process for the preparation of controlled release tablet
12/22/2011	WO2011157722A2 Solid ivabradine-containing composition
12/22/2011	WO2011157721A2 Ivabradine-containing pharmaceutical composition
12/22/2011	WO2011157720A2 Ivabradine-containing pharmaceutical composition with modified release
12/22/2011	WO2011157719A1 An injectable dosage form of flupirtine
12/22/2011	WO2011157449A1 Gel formulations for the topical use of 1-amino-alkylcyclohexane derivatives
12/22/2011	WO2011157428A2 In-situ lecithin microemulsion gel formulation
12/22/2011	WO2011157416A2 Transdermal administration of memantine
12/22/2011	WO2011157227A1 Compounds having activating effect on subtypes of peroxisome proliferator-activated receptors and its preparation method and uses
12/22/2011	WO2011156880A1 Colloidal nanoscale carriers for active hydrophilic substances and method for producing same
12/22/2011	WO2011139348A9 Uses of phospholipid conjugates of synthetic tlr7 agonists
12/22/2011	WO2011135536A3 Novel ruminant feed
12/22/2011	WO2011131787A3 Antibody preparations
12/22/2011	WO2011131786A3 Process for preparing an immunoglobulin composition
12/22/2011	WO2011131368A3 A method of preparing an oral dosage form comprising fingolimod
12/22/2011	WO2011125075A3 A gastro- retentive delivery of macrolide
12/22/2011	WO2011119247A3 Topical skincare composition
12/22/2011	WO2011107522A3 Foam formulations containing at least one triterpenoid
12/22/2011	WO2011097347A3 Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses
12/22/2011	WO2011093825A3 Effervescent dosage forms comprising cephalosporin antibiotic
12/22/2011	WO2011093824A3 Effervescent formulations comprising cefaclor
12/22/2011	WO2011088456A3 Methods and compositions for nanoparticle-mediated cancer cell-targeted delivery
12/22/2011	WO2011066291A4 Lyophilization methods, compositions, and kits
12/22/2011	WO2011051486A3 Pharmaceutical solution of non covalently bound albumin and acylated insulin
12/22/2011	WO2011050947A8 Tape, in particular, adhesive tape, for the treatment of skin disorders comprising at least one hyperkeratosis inhibitor and/or at least one keratinolytic agent
12/22/2011	WO2011012816A3 Pharmaceutical formulation
12/22/2011	WO2011005646A3 Pharmaceutical composition for a hepatitis c viral protease inhibitor
12/22/2011	WO2010143004A3 Glycerol-free osmotic laxative suppository
12/22/2011	WO2010136594A3 Injectable combination of adrenergic receptor agonists with fillers, for decreasing skin reactions due to injection
12/22/2011	US20110313540 in or relating to growing cells
12/22/2011	US20110313372 Transdermal administration of memantine
12/22/2011	US20110313348 Novel drug delivery technology
12/22/2011	US20110313051 Delivery system for topical medications
12/22/2011	US20110313036 CRYSTALLINE FORM OF y-AMINOBUTYRIC ACID ANALOG
12/22/2011	US20110313005 Topically applicable pharmaceutical preparation
12/22/2011	US20110312913 Method and pharmaceutical to treat spinal discs
12/22/2011	US20110312889 Sustained release of microcrystalline peptide suspensions
12/22/2011	US20110311712 Capsule comprising low-substituted cellulose ether and method for preparing the same
12/22/2011	US20110311639 Facile Route to the Synthesis of Resorcinarene Nanocapsules
12/22/2011	US20110311637 Methods and medicaments for administration of ibuprofen
12/22/2011	US20110311636 Methods and medicaments for administration of ibuprofen
12/22/2011	US20110311635 Hollow metal oxide spheres and nanoparticles encapsulated therein
12/22/2011	US20110311634 Formulations for animal feed comprising butyrate salt
12/22/2011	US20110311633 Combination of a Silicon Containing Component and a Hormone
12/22/2011	US20110311632 Stable chitosan hemostatic external patch and methods of manufacture
12/22/2011	US20110311631 Controlled release pharmaceutical composition with resistance against the influence of ethanol employing a coating comprising a polymer mixture and excipients
12/22/2011	US20110311630 Novel embedment particles for inhalation
12/22/2011	US20110311629 Non-adhesive elastic gelatin matrices
12/22/2011	US20110311628 Pulsatile release composition of therapeutic agent
12/22/2011	US20110311627 Controlled release levetiracetam formulations and methods for producing the same
12/22/2011	US20110311626 Controlled release compositions comprising anti-cholinergic drugs
12/22/2011	US20110311625 Solid dosage forms of fenofibrate
12/22/2011	US20110311624 Formulations of histone deacetylase inhibitor and uses thereof
12/22/2011	US20110311623 Composition for manufacturing orally disintegrating dosage form to protect coating layer of active substance
12/22/2011	US20110311622 Method for adding sensory conditioning cues in a pharmacotherapeutic regimen
12/22/2011	US20110311621 Pharmaceutical compositions and methods of delvery
12/22/2011	US20110311620 Novel modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors
12/22/2011	US20110311619 Pharmaceutical formulation of nanonised fenofibrate
12/22/2011	US20110311618 Inhalable particles comprising tiotropium
12/22/2011	US20110311617 Oral vaccine
12/22/2011	US20110311616 Targeting tumor associated macrophages using bisphosphonate-loaded particles
12/22/2011	US20110311615 Novel gp41 antigens
12/22/2011	US20110311614 Splitting gp41
12/22/2011	US20110311613 Topical formulations of flap inhibitors for the treatment of dermatological conditions
12/22/2011	US20110311612 Humanized Neuraminidase Antibody and Methods of Use Thereof
12/22/2011	US20110311611 Water dissolvable adherent article for topical application
12/22/2011	US20110311609 Wound healing device
12/22/2011	US20110311608 Stable chitosan hemostatic implant and methods of manufacture
12/22/2011	US20110311599 Granulated powder containing vegetable proteins and fibers, process for producing same, and use thereof

1 ... 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 ... 2991